R. E. Marcus

CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma

R. E. Marcus · Blood · 2004 · 966 citations · Full text

Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial

KM Ardeshna, Peter Smith, AJ Norton et al. · The Lancet · 2003 · 538 citations

Lymphoid Neoplasia, Long-term Effect, Health Policy +4

A multicentre, open, non‐comparative phase II study of a combination of fludarabine phosphate, cytarabine and granulocyte colony‐stimulating factor in relapsed and refractory acute myeloid leukaemia and <i>de novo</i> refractory anaemia with excess of blasts in transformation

Graham Jackson, P R Taylor, Graeme Smith et al. · British Journal of Haematology · 2001 · 110 citations · Full text

Intensive chemotherapy and low-dose radiotherapy for the treatment of advanced-stage Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study.

Michael A. Weiner, Brigid G. Leventhal, R. E. Marcus et al. · Journal of Clinical Oncology · 1991 · 78 citations

Low-dose Radiotherapy, Pathology, Pharmacotherapy +19

Activity of Oral Fludarabine Phosphate in Previously Treated Chronic Lymphocytic Leukemia

M. Boogaerts, Ambro van Hoof, Daniel Catovsky et al. · Journal of Clinical Oncology · 2001 · 69 citations